A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Amgen Inc stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 70,016 shares of AMGN stock, worth $22.1 Million. This represents 2.48% of its overall portfolio holdings.

Number of Shares
70,016
Previous 68,543 2.15%
Holding current value
$22.1 Million
Previous $21.4 Million 5.34%
% of portfolio
2.48%
Previous 2.59%

Shares

52 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$309.38 - $337.38 $455,716 - $496,960
1,473 Added 2.15%
70,016 $22.6 Million
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $329,225 - $400,095
1,253 Added 1.86%
68,543 $21.4 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $251,124 - $303,139
934 Added 1.41%
67,290 $19.1 Million
Q4 2023

Jan 16, 2024

BUY
$255.7 - $288.46 $232,431 - $262,210
909 Added 1.39%
66,356 $19.1 Million
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $299,769 - $372,171
1,371 Added 2.14%
65,447 $17.6 Million
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $332,332 - $392,976
1,551 Added 2.48%
64,076 $14.2 Million
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $368,715 - $449,401
1,633 Added 2.68%
62,525 $15.1 Million
Q4 2022

Jan 17, 2023

BUY
$229.03 - $291.01 $228,342 - $290,136
997 Added 1.66%
60,892 $0
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $265,985 - $299,982
1,185 Added 2.02%
59,895 $13.5 Million
Q2 2022

Jul 14, 2022

BUY
$230.71 - $256.74 $84,901 - $94,480
368 Added 0.63%
58,710 $14.3 Million
Q1 2022

Apr 25, 2022

BUY
$219.27 - $242.57 $176,073 - $194,783
803 Added 1.4%
58,342 $14.1 Million
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $356,989 - $408,542
1,795 Added 3.22%
57,539 $12.9 Million
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $61,558 - $72,123
290 Added 0.52%
55,744 $11.9 Million
Q2 2021

Jul 27, 2021

BUY
$233.58 - $259.14 $333,318 - $369,792
1,427 Added 2.64%
55,454 $13.5 Million
Q1 2021

Apr 27, 2021

SELL
$221.91 - $258.6 $37,724 - $43,962
-170 Reduced 0.31%
54,027 $13.4 Million
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $165,530 - $197,117
765 Added 1.43%
54,197 $12.5 Million
Q3 2020

Oct 14, 2020

BUY
$234.65 - $260.95 $35,901 - $39,925
153 Added 0.29%
53,432 $13.6 Million
Q2 2020

Jul 14, 2020

BUY
$197.81 - $242.74 $96,729 - $118,699
489 Added 0.93%
53,279 $12.6 Million
Q1 2020

Apr 20, 2020

SELL
$182.24 - $241.7 $437,558 - $580,321
-2,401 Reduced 4.35%
52,790 $10.7 Million
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $61,493 - $79,040
-325 Reduced 0.59%
55,191 $13.3 Million
Q3 2019

Oct 30, 2019

BUY
$174.11 - $208.62 $13,406 - $16,063
77 Added 0.14%
55,516 $10.7 Million
Q2 2019

Jul 15, 2019

SELL
$166.7 - $195.41 $6,834 - $8,011
-41 Reduced 0.07%
55,439 $10.2 Million
Q1 2019

Apr 18, 2019

SELL
$180.87 - $203.88 $136,195 - $153,521
-753 Reduced 1.34%
55,480 $10.5 Million
Q4 2018

Jan 18, 2019

BUY
$178.4 - $208.25 $34,252 - $39,984
192 Added 0.34%
56,233 $10.9 Million
Q3 2018

Oct 11, 2018

SELL
$185.29 - $208.89 $300,725 - $339,028
-1,623 Reduced 2.81%
56,041 $11.6 Million
Q2 2018

Sep 14, 2018

BUY
$166.05 - $186.51 $162,562 - $182,593
979 Added 1.73%
57,664 $10.6 Million
Q1 2018

Sep 14, 2018

SELL
$169.43 - $198.0 $234,829 - $274,428
-1,386 Reduced 2.39%
56,685 $9.66 Million
Q4 2017

Sep 14, 2018

SELL
$168.79 - $188.59 $540,634 - $604,053
-3,203 Reduced 5.23%
58,071 $10.1 Million
Q3 2017

Sep 14, 2018

BUY
$167.29 - $191.0 $35,632 - $40,683
213 Added 0.35%
61,274 $11.4 Million
Q2 2017

Sep 13, 2018

BUY
N/A
1,927 Added 3.26%
61,061 $10.4 Million
Q1 2017

Sep 13, 2018

BUY
N/A
2,550 Added 4.51%
59,134 $9.62 Million
Q4 2016

Sep 13, 2018

BUY
N/A
2,785 Added 5.18%
56,584 $8.18 Million
Q3 2016

Sep 13, 2018

BUY
N/A
627 Added 1.18%
53,799 $8.86 Million
Q2 2016

Sep 13, 2018

BUY
N/A
2,739 Added 5.43%
53,172 $7.97 Million
Q1 2016

Sep 13, 2018

BUY
N/A
568 Added 1.14%
50,433 $7.42 Million
Q4 2015

Sep 13, 2018

SELL
N/A
-147 Reduced 0.29%
49,865 $7.94 Million
Q3 2015

Sep 13, 2018

BUY
N/A
1,597 Added 3.3%
50,012 $6.78 Million
Q2 2015

Sep 13, 2018

BUY
N/A
587 Added 1.23%
48,415 $7.28 Million
Q1 2015

Sep 13, 2018

BUY
N/A
485 Added 1.02%
47,828 $7.49 Million
Q4 2014

Sep 13, 2018

SELL
N/A
-3,238 Reduced 6.4%
47,343 $7.41 Million
Q3 2014

Sep 13, 2018

SELL
N/A
-1,733 Reduced 3.31%
50,581 $6.99 Million
Q2 2014

Sep 13, 2018

BUY
N/A
2,406 Added 4.82%
52,314 $6.1 Million
Q1 2014

Sep 13, 2018

BUY
N/A
2,973 Added 6.33%
49,908 $6.11 Million
Q4 2013

Sep 13, 2018

BUY
N/A
5,214 Added 12.5%
46,935 $5.31 Million
Q3 2013

Sep 13, 2018

BUY
N/A
623 Added 1.52%
41,721 $4.63 Million
Q2 2013

Sep 13, 2018

BUY
N/A
4,911 Added 13.57%
41,098 $4.02 Million
Q1 2013

Sep 13, 2018

BUY
N/A
51 Added 0.14%
36,187 $3.67 Million
Q4 2012

Sep 13, 2018

SELL
N/A
-249 Reduced 0.68%
36,136 $3.08 Million
Q3 2012

Sep 13, 2018

SELL
N/A
-10,924 Reduced 23.09%
36,385 $3.03 Million
Q2 2012

Sep 13, 2018

SELL
N/A
-524 Reduced 1.1%
47,309 $3.41 Million
Q1 2012

Sep 13, 2018

SELL
N/A
-458 Reduced 0.95%
47,833 $3.21 Million
Q4 2011

Sep 13, 2018

BUY
N/A
48,291
48,291 $3.07 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Steigerwald, Gordon & Koch Inc. Portfolio

Follow Steigerwald, Gordon & Koch Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.